Emerging markets represent an exceptional opportunity for the pharmaceutical and medtec industry from established economies. But conquering them can be challenging in terms of infrastructure development, cost-containment policies, and value-driven drug evaluation.
Besides Germany, the further key markets of Europe –France, Great Britain, Italy and Spain, are familiar to us. In the US, the biggest pharma and medtec market worldwide we maintain a longterm business relationship with our senior partner.
For companies from emerging markets we offer the gateway to Europe for certification, studies, market and riembursement and key opionion leader management. Right from the heart of Europe.